946 related articles for article (PubMed ID: 31262891)
1. Inhibition of Pancreatic Carcinoma Growth Through Enhancing ω-3 Epoxy Polyunsaturated Fatty Acid Profile by Inhibition of Soluble Epoxide Hydrolase.
Xia R; Sun L; Liao J; Li H; You X; Xu D; Yang J; Hwang SH; Jones RD; Hammock B; Yang GY
Anticancer Res; 2019 Jul; 39(7):3651-3660. PubMed ID: 31262891
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of soluble epoxide hydrolase modulates inflammation and autophagy in obese adipose tissue and liver: role for omega-3 epoxides.
López-Vicario C; Alcaraz-Quiles J; García-Alonso V; Rius B; Hwang SH; Titos E; Lopategi A; Hammock BD; Arroyo V; Clària J
Proc Natl Acad Sci U S A; 2015 Jan; 112(2):536-41. PubMed ID: 25550510
[TBL] [Abstract][Full Text] [Related]
3. A diet rich in omega-3 fatty acids enhances expression of soluble epoxide hydrolase in murine brain.
Ostermann AI; Reutzel M; Hartung N; Franke N; Kutzner L; Schoenfeld K; Weylandt KH; Eckert GP; Schebb NH
Prostaglandins Other Lipid Mediat; 2017 Nov; 133():79-87. PubMed ID: 28583889
[TBL] [Abstract][Full Text] [Related]
4. Endogenous n-3 polyunsaturated fatty acids delay progression of pancreatic ductal adenocarcinoma in Fat-1-p48(Cre/+)-LSL-Kras(G12D/+) mice.
Mohammed A; Janakiram NB; Brewer M; Duff A; Lightfoot S; Brush RS; Anderson RE; Rao CV
Neoplasia; 2012 Dec; 14(12):1249-59. PubMed ID: 23308056
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of mutant KrasG12D-initiated murine pancreatic carcinoma growth by a dual c-Raf and soluble epoxide hydrolase inhibitor t-CUPM.
Liao J; Hwang SH; Li H; Yang Y; Yang J; Wecksler AT; Liu JY; Hammock BD; Yang GY
Cancer Lett; 2016 Feb; 371(2):187-93. PubMed ID: 26683769
[TBL] [Abstract][Full Text] [Related]
6. Lipid mediators generated by the cytochrome P450-Epoxide hydrolase pathway.
Frömel T; Hu J; Fleming I
Adv Pharmacol; 2023; 97():327-373. PubMed ID: 37236763
[TBL] [Abstract][Full Text] [Related]
7. Epoxy-Oxylipins and Soluble Epoxide Hydrolase Metabolic Pathway as Targets for NSAID-Induced Gastroenteropathy and Inflammation-Associated Carcinogenesis.
Jones RD; Liao J; Tong X; Xu D; Sun L; Li H; Yang GY
Front Pharmacol; 2019; 10():731. PubMed ID: 31293429
[TBL] [Abstract][Full Text] [Related]
8. Modulation of the endogenous omega-3 fatty acid and oxylipin profile in vivo-A comparison of the fat-1 transgenic mouse with C57BL/6 wildtype mice on an omega-3 fatty acid enriched diet.
Ostermann AI; Waindok P; Schmidt MJ; Chiu CY; Smyl C; Rohwer N; Weylandt KH; Schebb NH
PLoS One; 2017; 12(9):e0184470. PubMed ID: 28886129
[TBL] [Abstract][Full Text] [Related]
9. Cardioprotective mechanisms of cytochrome P450 derived oxylipins from ω-3 and ω-6 PUFAs.
Cho C; Aliwarga T; Wiley AM; Totah RA
Adv Pharmacol; 2023; 97():201-227. PubMed ID: 37236759
[TBL] [Abstract][Full Text] [Related]
10. Overexpression and hyperactivity of breast cancer-associated fatty acid synthase (oncogenic antigen-519) is insensitive to normal arachidonic fatty acid-induced suppression in lipogenic tissues but it is selectively inhibited by tumoricidal alpha-linolenic and gamma-linolenic fatty acids: a novel mechanism by which dietary fat can alter mammary tumorigenesis.
Menendez JA; Ropero S; Mehmi I; Atlas E; Colomer R; Lupu R
Int J Oncol; 2004 Jun; 24(6):1369-83. PubMed ID: 15138577
[TBL] [Abstract][Full Text] [Related]
11. Anti-inflammatory effects of ω-3 polyunsaturated fatty acids and soluble epoxide hydrolase inhibitors in angiotensin-II-dependent hypertension.
Ulu A; Harris TR; Morisseau C; Miyabe C; Inoue H; Schuster G; Dong H; Iosif AM; Liu JY; Weiss RH; Chiamvimonvat N; Imig JD; Hammock BD
J Cardiovasc Pharmacol; 2013 Sep; 62(3):285-97. PubMed ID: 23676336
[TBL] [Abstract][Full Text] [Related]
12. The ω-3 epoxide of eicosapentaenoic acid inhibits endothelial cell proliferation by p38 MAP kinase activation and cyclin D1/CDK4 down-regulation.
Cui PH; Petrovic N; Murray M
Br J Pharmacol; 2011 Mar; 162(5):1143-55. PubMed ID: 21077851
[TBL] [Abstract][Full Text] [Related]
13. Effects of Individual Circulating FFAs on Plasma and Hepatic FFA Epoxides, Diols, and Epoxide-Diol Ratios as Indices of Soluble Epoxide Hydrolase Activity.
Oh YT; Yang J; Morisseau C; He Q; Hammock B; Youn JH
Int J Mol Sci; 2023 Jun; 24(13):. PubMed ID: 37445935
[TBL] [Abstract][Full Text] [Related]
14. Dietary EPA and DHA prevent changes in white adipose tissue omega-3 PUFA and oxylipin content associated with a Fads2 deficiency.
Sarr O; Payne GW; Hucik B; Abdelmagid S; Nakamura MT; Ma DWL; Mutch DM
J Nutr Biochem; 2019 Jan; 63():140-149. PubMed ID: 30368227
[TBL] [Abstract][Full Text] [Related]
15. Elevated tissue omega-3 fatty acid status prevents age-related glucose intolerance in fat-1 transgenic mice.
Romanatto T; Fiamoncini J; Wang B; Curi R; Kang JX
Biochim Biophys Acta; 2014 Feb; 1842(2):186-91. PubMed ID: 24211484
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of Chronic Pancreatitis and Murine Pancreatic Intraepithelial Neoplasia by a Dual Inhibitor of c-RAF and Soluble Epoxide Hydrolase in LSL-KrasG¹²D/Pdx-1-Cre Mice.
Liao J; Hwang SH; Li H; Liu JY; Hammock BD; Yang GY
Anticancer Res; 2016 Jan; 36(1):27-37. PubMed ID: 26722025
[TBL] [Abstract][Full Text] [Related]
17. Modulation of blood oxylipin levels by long-chain omega-3 fatty acid supplementation in hyper- and normolipidemic men.
Schuchardt JP; Schmidt S; Kressel G; Willenberg I; Hammock BD; Hahn A; Schebb NH
Prostaglandins Leukot Essent Fatty Acids; 2014; 90(2-3):27-37. PubMed ID: 24411718
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of the HER2 pathway by n-3 polyunsaturated fatty acids prevents breast cancer in fat-1 transgenic mice.
Zou Z; Bellenger S; Massey KA; Nicolaou A; Geissler A; Bidu C; Bonnotte B; Pierre AS; Minville-Walz M; Rialland M; Seubert J; Kang JX; Lagrost L; Narce M; Bellenger J
J Lipid Res; 2013 Dec; 54(12):3453-63. PubMed ID: 24052576
[TBL] [Abstract][Full Text] [Related]
19. fat-1 transgene expression prevents cell culture-induced loss of membrane n-3 fatty acids in activated CD4+ T-cells.
Fan YY; Kim W; Callaway E; Smith R; Jia Q; Zhou L; McMurray DN; Chapkin RS
Prostaglandins Leukot Essent Fatty Acids; 2008 Dec; 79(6):209-14. PubMed ID: 18977126
[TBL] [Abstract][Full Text] [Related]
20. Eicosanoid profiles in an arthritis model: Effects of a soluble epoxide hydrolase inhibitor.
Trindade-da-Silva CA; Yang J; Fonseca F; Pham H; Napimoga MH; Abdalla HB; Aver G; De Oliveira MJA; Hammock BD; Clemente-Napimoga JT
Biochim Biophys Acta Mol Cell Biol Lipids; 2024 Mar; 1869(2):159432. PubMed ID: 37984607
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
